Immunoprecise Stock Probability of Future Stock Price Finishing Over 3.99

IPA
 Stock
  

USD 3.99  0.15  3.62%   

Immunoprecise Antibodies' future price is the expected price of Immunoprecise Antibodies instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Immunoprecise Antibodies performance during a given time horizon utilizing its historical volatility. As of June 27, 2022, Price to Book Value is expected to decline to 3.19. In addition to that, Price to Earnings Ratio is expected to decline to -25.91.
  
Refresh
Immunoprecise Antibodies' implied volatility is one of the determining factors in the pricing options written on Immunoprecise Antibodies. Implied volatility approximates the future value of Immunoprecise Antibodies based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Immunoprecise Antibodies over a specific time period. For example, 2022-07-15 CALL at $5.0 is a CALL option contract on Immunoprecise Antibodies' common stock with a strick price of 5.0 expiring on 2022-07-15. The contract was last traded on 2022-06-21 at 10:00:06 for $0.2 and, as of today, has 18 days remaining before the expiration. The option is currently trading at a bid price of $0.1, and an ask price of $0.25. The implied volatility as of the 27th of June is 111.8987. View All Immunoprecise options

Closest to current price Immunoprecise long CALL Option Payoff at Expiration

Please see Immunoprecise Antibodies Backtesting, Immunoprecise Antibodies Valuation, Immunoprecise Antibodies Correlation, Immunoprecise Antibodies Hype Analysis, Immunoprecise Antibodies Volatility, Immunoprecise Antibodies History as well as Immunoprecise Antibodies Performance. Please specify Immunoprecise Antibodies time horizon, a valid symbol (red box) and a target price (blue box) you would like Immunoprecise Antibodies odds to be computed.
Apply Odds

Immunoprecise Antibodies Target Price Odds to finish over 3.99

The tendency of Immunoprecise Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 3.99 90 days 3.99  over 95.63
Based on a normal probability distribution, the odds of Immunoprecise Antibodies to move above the current price in 90 days from now is over 95.63 (This Immunoprecise Antibodies probability density function shows the probability of Immunoprecise Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon the stock has the beta coefficient of 1.16 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Immunoprecise Antibodies will likely underperform. Additionally The company has an alpha of 0.2443, implying that it can generate a 0.24 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Immunoprecise Antibodies Price Density 
      Price 

Predictive Modules for Immunoprecise Antibodies

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Immunoprecise Antibodies. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Immunoprecise Antibodies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Immunoprecise Antibodies in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.204.048.51
Details
Intrinsic
Valuation
LowReal ValueHigh
1.475.9410.41
Details
1 Analysts
Consensus
LowTarget PriceHigh
12.0012.0012.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Immunoprecise Antibodies. Your research has to be compared to or analyzed against Immunoprecise Antibodies' peers to derive any actionable benefits. When done correctly, Immunoprecise Antibodies' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Immunoprecise Antibodies.

Immunoprecise Antibodies Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Immunoprecise Antibodies is not an exception. The market had few large corrections towards the Immunoprecise Antibodies' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Immunoprecise Antibodies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Immunoprecise Antibodies within the framework of very fundamental risk indicators.
α
Alpha over DOW
0.24
β
Beta against DOW1.16
σ
Overall volatility
0.62
Ir
Information ratio 0.04673

Immunoprecise Antibodies Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Immunoprecise Antibodies for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Immunoprecise Antibodies can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Immunoprecise Antibodies generated a negative expected return over the last 90 days
Immunoprecise Antibodies has high historical volatility and very poor performance
Immunoprecise Antibodies was previously known as IMMUNOPRECISE ANTIBODIES LTD and was traded on NASDAQ Exchange under the symbol IPATF.
The company reported the last year's revenue of 19 M. Reported Net Loss for the year was (17.1 M) with profit before taxes, overhead, and interest of 11.4 M.
Immunoprecise Antibodies has about 32.99 M in cash with (8.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.7.
Immunoprecise Antibodies has a poor financial position based on the latest SEC disclosures

Immunoprecise Antibodies Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Immunoprecise Stock often depends not only on the future outlook of the current and potential Immunoprecise Antibodies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Immunoprecise Antibodies' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out1.24%
Float Shares15.67M
Shares Short Prior Month282.2k
Average Daily Volume Last 10 Day15.05k
Average Daily Volume In Three Month24.92k
Date Short Interest29th of April 2022

Immunoprecise Antibodies Technical Analysis

Immunoprecise Antibodies' future price can be derived by breaking down and analyzing its technical indicators over time. Immunoprecise Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Immunoprecise Antibodies. In general, you should focus on analyzing Immunoprecise Stock price patterns and their correlations with different microeconomic environments and drivers.

Immunoprecise Antibodies Predictive Forecast Models

Immunoprecise Antibodies time-series forecasting models is one of many Immunoprecise Antibodies' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Immunoprecise Antibodies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Immunoprecise Antibodies

Checking the ongoing alerts about Immunoprecise Antibodies for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Immunoprecise Antibodies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Immunoprecise Antibodies Alerts

Immunoprecise Antibodies Alerts and Suggestions

Immunoprecise Antibodies generated a negative expected return over the last 90 days
Immunoprecise Antibodies has high historical volatility and very poor performance
Immunoprecise Antibodies was previously known as IMMUNOPRECISE ANTIBODIES LTD and was traded on NASDAQ Exchange under the symbol IPATF.
The company reported the last year's revenue of 19 M. Reported Net Loss for the year was (17.1 M) with profit before taxes, overhead, and interest of 11.4 M.
Immunoprecise Antibodies has about 32.99 M in cash with (8.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.7.
Immunoprecise Antibodies has a poor financial position based on the latest SEC disclosures
Please see Immunoprecise Antibodies Backtesting, Immunoprecise Antibodies Valuation, Immunoprecise Antibodies Correlation, Immunoprecise Antibodies Hype Analysis, Immunoprecise Antibodies Volatility, Immunoprecise Antibodies History as well as Immunoprecise Antibodies Performance. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fund Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
98 M
Quarterly Revenue Growth YOY
0.066
Return On Assets
-0.19
Return On Equity
-0.43
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.